Skip to main content
. 2020 Mar 21;21(6):2161. doi: 10.3390/ijms21062161

Figure 3.

Figure 3

PFS and OS comparison between four patient subgroups based on therapeutically relevant receptor change or stable patterns between PTs and MTs. Ø—negative; ER—estrogen receptor; HER2—human epidermal growth factor receptor 2.